To further evaluate whether BTC may improve the skin barrier function in pathophysiological conditions, we examined the effect of BTC on the skin barrier function in human skin equivalents and in an in vitro AD-like model established by treating skin equivalents with the Th2-type cytokines IL-4 and IL-13 [14]. The gene discussed is IL13; the disease is Alzheimer disease.